These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 1752142)

  • 21. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction.
    Campbell DJ; Mitchelhill KI; Schlicht SM; Booth RJ
    J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
    Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
    Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma bradykinin levels in human chronic congestive heart failure.
    Cugno M; Agostoni P; Brunner HR; Gardinali M; Agostoni A; Nussberger J
    Clin Sci (Lond); 2000 Nov; 99(5):461-6. PubMed ID: 11052927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of naloxone on plasma levels of atrial natriuretic factor and noradrenaline during water load in moderate heart failure].
    Tarsi G; Paradossi U; Tartuferi L; Schipani A; Palmisano D; De Iasio R; Carboni L; Fontana F; Bernardi P
    G Ital Cardiol; 1996 Aug; 26(8):879-85. PubMed ID: 9005170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Changes in growth hormone/insulin-like growth factor-1 axis in patients with normal pituitary function and biventricular cardiac failure and hepatic stasis].
    Mangieri E; Tosti-Croce C; Tanzilli G; Barillà F; Nardi M; Poggi M; Ciavolella M; Farinelli A; Mangiaracina F; Campa PP
    Cardiologia; 1996 May; 41(5):449-53. PubMed ID: 8767634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoantibodies: new upstream targets of paroxysmal atrial fibrillation in patients with congestive heart failure].
    Baba A; Yoshikawa T; Chino M; Murayama A; Mitani K; Nakagawa S; Fujii I; Shimada M; Koyama T; Akaishi M; Mitamura H; Ogawa S;
    J Cardiol; 2002 Nov; 40(5):217-23. PubMed ID: 12463096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic value of brain natriuretic peptide and β-endorphin plasma concentration changes in patients with acute left heart failure and atrial fibrillation.
    Feng SD; Jiang Y; Lin ZH; Lin PH; Lin SM; Liu QC
    Medicine (Baltimore); 2017 Aug; 96(34):e7526. PubMed ID: 28834870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Changes in plasma immunoreactive beta-endorphin in burn and its clinical significance].
    Xue JZ
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1991 Dec; 7(4):253-6, 317. PubMed ID: 1811838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated plasma beta-endorphin levels in patients with congestive heart failure.
    Kawashima S; Fukutake N; Nishian K; Asakuma S; Iwasaki T
    J Am Coll Cardiol; 1991 Jan; 17(1):53-8. PubMed ID: 1987240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta-endorphin secretion at the time of sudden death due to cardiac or respiratory failure.
    Tsunoda K; Douge K; Akiya Y; Watanabe T
    Nihon Hoigaku Zasshi; 1992 Jun; 46(3):182-8. PubMed ID: 1405012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma beta-endorphin response to exercise in patients with congestive heart failure.
    Perna GP; Modoni S; Valle G; Stanislao M; Loperfido F
    Chest; 1997 Jan; 111(1):19-22. PubMed ID: 8995987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for in vivo high-frequency periodicity of plasma beta-endorphin in humans.
    Imthurn B; Rosselli M; Beran J; Keller PJ
    Horm Metab Res; 1995 Apr; 27(4):189-93. PubMed ID: 7750903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Changes in plasma immunologic reactive beta-endorphin and their effect on lymphocyte response to phytohemagglutinin after thermal injury].
    Lu SL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1992 Sep; 8(3):196-8, 248. PubMed ID: 1298532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation and inhibition of the endogenous opioid system in human heart failure.
    Oldroyd KG; Gray CE; Carter R; Harvey K; Borland W; Beastall G; Cobbe SM
    Br Heart J; 1995 Jan; 73(1):41-8. PubMed ID: 7888260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.